肺炎検査の世界市場2017-2021...市場調査レポートについてご紹介

【英文タイトル】Global Pneumonia Testing Market 2017-2021

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

PART 01: Executive summary

PART 02: Scope of  the report

Market overview
Top-vendor offerings

PART 03: Market research methodology

Research methodology
Economic indicators

PART 04: Introduction

Key market highlights
Pneumonia: An overview
Market snapshot

PART 05: Market landscape

Market overview
Market size and forecast
Buying criteria
Five forces analysis

PART 06: Market segmentation by product type

Global pneumonia testing market by analyzers
Global pneumonia testing market by consumables

PART 07: Market segmentation by method

Immunodiagnostics
Molecular diagnostics
POC
Global pneumonia testing market by immunodiagnostics
Global pneumonia testing market by molecular diagnostics
Global pneumonia testing market by POC

PART 08: Market segmentation by technology

ELISA
Immunofluorescence
Western blot
PCR
IHC
NASBA
Others

PART 09: Market segmentation by end-user
Hospitals
Diagnostic laboratories
Homecare
Others

PART 10: Geographical segmentation

Pneumonia testing market in the Americas
Pneumonia testing market in EMEA
Pneumonia testing market in APAC

PART 11: Market drivers

Increased awareness regarding early diagnosis and preventive measures
Growing popularity of POC testing
Marketing strategies of vendors
Improvement in healthcare infrastructure

PART 12: Impact of drivers

PART 13: Market challenges

Limited detection capability and accuracy
Presence of an undiagnosed population
Regulatory and economic hurdles

PART 14: Impact of drivers and challenges

PART 15: Market trends

Increase in adoption of molecular diagnostic testing
Growing consumer shift toward direct-to-consumer testing
Shift from monoplex to multiplex testing

PART 16: Vendor landscape

Competitive scenario
Market share analysis
Geographical presence of the key vendors
Key news

PART 17: Key vendor analysis

Abbott Molecular
bioMérieux
BD0
Roche Molecular Diagnostics
Thermo Fisher Scientific
Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings

Exhibit 02: Global pneumonia testing market by type 2016

Exhibit 03: Global pneumonia testing market: Analysis

Exhibit 04: Yearly prevalence of pneumonia, region wise

Exhibit 05: Market overview: Global pneumonia testing market

Exhibit 06: Global pneumonia testing market 2016-2021 ($ millions)

Exhibit 07: Global pneumonia testing market analysis: Developed and emerging markets

Exhibit 08: Key buying criteria in global pneumonia testing market

Exhibit 09: Buying criteria for pneumonia testing

Exhibit 10: Five forces analysis

Exhibit 11: Global pneumonia testing market segmentation by product type 2016

Exhibit 12: Global pneumonia testing market segmentation by product type 2021

Exhibit 13: Market overview: Global pneumonia testing market by analyzers

Exhibit 14: Global pneumonia testing market by analyzers 2016-2021 ($ millions)

Exhibit 15: Market overview: Global pneumonia testing market by consumables

Exhibit 16: Global pneumonia testing market by consumables 2016-2021 ($ millions)

Exhibit 17: Segmentation of pneumonia testing market by product type 2016-2021 ($ millions)

Exhibit 18: Segmentation of global pneumonia testing market by product type 2016-2021 (%)

Exhibit 19: Global pneumonia testing market by method

Exhibit 20: Global pneumonia testing market segmentation by method 2016

Exhibit 21: Global pneumonia testing market segmentation by method 2021

Exhibit 22: Global pneumonia testing market by immunodiagnostics 2016-2021 ($ millions)

Exhibit 23: Global pneumonia testing market by molecular diagnostics 2016-2021 ($ millions)

Exhibit 24: Global pneumonia testing market by POC 2016-2021 ($ millions)

Exhibit 25: Segmentation of pneumonia testing market by method 2016-2021 ($ millions)

Exhibit 26: Segmentation of pneumonia testing market by product type 2016-2021 (%)

Exhibit 27: Global pneumonia testing market by technology

Exhibit 28: Global pneumonia testing market by technology 2016

Exhibit 29: Global pneumonia testing market segmentation by end-users 2016

Exhibit 30: Global pneumonia testing market segmentation by geography 2016

Exhibit 31: Global pneumonia testing market segmentation by geography 2021

Exhibit 32: Global pneumonia testing market: Country-wise revenue and growth analysis 2016

Exhibit 33: Global pneumonia testing market: Geography lifecycle analysis 2016

Exhibit 34: Market overview: Americas

Exhibit 35: Pneumonia testing market in Americas 2016-2021 ($ millions)

Exhibit 36: Country-wise analysis: Americas

Exhibit 37: Market overview: EMEA

Exhibit 38: Pneumonia testing market in EMEA 2016-2021 ($ millions)

Exhibit 39: Country-wise analysis: EMEA

Exhibit 40: Market overview: APAC

Exhibit 41: Pneumonia testing market in APAC 2016-2021 ($ millions)

Exhibit 42: Country-wise analysis: APAC

Exhibit 43: Global pneumonia testing market segmentation by geography 2016-2021 (%)

Exhibit 44: Global pneumonia testing market segmentation by geography 2016-2021 ($ millions)

Exhibit 45: Geographical overview: Global pneumonia testing market

Exhibit 46: Yearly country-wise death rates per 100,000 population due to pneumonia on average 2015

Exhibit 47: Marketing strategies of global vendors

Exhibit 48: Impact of drivers

Exhibit 49: Recent initiatives taken to combat antibiotic resistance

Exhibit 50: Country-wise regulatory requirements

Exhibit 51: Impact of drivers and challenges

Exhibit 52: Acquisitions by global vendors in 2016

Exhibit 53: Competitive structure analysis of global pneumonia testing market 2016

Exhibit 54: Market penetration of pneumonia testing manufacturers globally (2016)

Exhibit 55: Strategic success factors of companies in global pneumonia testing market 2016

Exhibit 56: Share of vendors in global pneumonia testing market 2016

Exhibit 57: Regional analysis of key vendors 2016

Exhibit 58: Key highlights of Abbott Molecular

Exhibit 59: Abbott Molecular: Strength assessment

Exhibit 60: Abbott Molecular: Strategy assessment

Exhibit 61: Abbott Molecular: Opportunity assessment

Exhibit 62: Key highlights of bioMérieux

Exhibit 63: bioMérieux: Strength assessment

Exhibit 64: bioMérieux: Strategy assessment

Exhibit 65: bioMérieux: Opportunity assessment

Exhibit 66: Key highlights of BD

Exhibit 67: BD: Strength assessment

Exhibit 68: BD: Strategy assessment

Exhibit 69: BD: Opportunity assessment

Exhibit 70: Key highlights of Roche Molecular Diagnostics

Exhibit 71: Roche Molecular Diagnostics: Strength assessment

Exhibit 72: Roche Molecular Diagnostics: Strategy assessment

Exhibit 73: Roche Molecular Diagnostics: Opportunity assessment

Exhibit 74: Key highlights of Thermo Fisher Scientific

Exhibit 75: Thermo Fisher Scientific: Strength assessment

Exhibit 76: Thermo Fisher Scientific: Strategy assessment

Exhibit 77: Thermo Fisher Scientific: Opportunity assessment


【レポート販売概要】

■ タイトル:肺炎検査の世界市場2017-2021
■ 英文:Global Pneumonia Testing Market 2017-2021
■ 発行日:2017年2月17日
■ 調査会社:Technavio
■ 商品コード:IRTNTR12037
■ 調査対象地域:世界
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。